I-MK-2866 vs LGD-4033: Ziyini?

Ostarine (MK-2866) kanye ne-Ligandrol (LGD-4033) ngokungangabazeki ezimbili ze-Selective Androgen Receptor Modulators (SARMs) ezaziwa kakhulu emhlabeni wokuqina nokwakha umzimba. Eminyakeni embalwa edlule, bobabili bathole ukuthandwa okuningi njengezinhlanganisela zokwakha imisipha. Nokho, umbuzo osengqondweni yawo wonke umuntu uwukuthi: iyiphi engcono?

 

I-Ostarine vs Ligandrol: Imvelaphi Nokufanayo

Ake siqale siqale ngalokho u-Ostarine (MK-2866) no-Ligandrol (LGD-4033) abahlanganyela ngakho, bese siqhubeka nokudiliza umehluko. 

Kokubili i-Ostarine ne-Ligandrol ngama-SARM aqale akhiqizwa izinkampani zemithi njengezinye izindlela zokwelapha esikhundleni se-androgen. Kuhle ukuqaphela lapha ukuthi lokhu kwelashwa kuhloselwe abantu abanenkinga yezempilo. Lokhu kungase kuhlanganise, kodwa akukhawulelwe ezimweni ezibangela ukuwohloka kwemisipha, njengomdlavuza, i-osteoporosis, nokukhubazeka kokukhula, kanye nokwelashwa kwangemva kokuhlinzwa kanye nezimo ezithile zokumosheka kwemisipha. 

Ngokuyisisekelo, izinkampani ezenza imithi zazifuna izixazululo ezazingenzima kakhulu emzimbeni njengama-anabolic steroids endabuko. 

Ngakho-ke, banqume ukudala i-Selective Androgen Receptor Modulators (SARMs) njenge-Ostarine (MK-2866) ne-Ligandrol (LGD-4033). Lawa ama-non-steroidal compounds asetshenziselwa ukwelashwa njengalezi ezibalwe ngenhla. 

Womabili lawa ma-SARM anamandla okubopha ama-androgen receptors ethanjeni nasezicubu. Lokhu kukhuthaza ukukhula kulezi zindawo, ukusheshisa ukuzuza kwemisipha nokuqinisa amathambo. 

Njengoba igama labo liphakamisa, ama-SARM akhetha kuma-androgen receptors abopha kuwo. Lokhu akunjalo ngama-steroids omklami, angase avele abophe kalula inhliziyo, i-prostate, noma ezinye izitho zokuzala. Ukukhula kulezi zindawo kuyingozi kakhulu. 

Lesi yisona sizathu esenza ukuthi ama-SARM athathwe njengaphephile kune-anabolic steroids. Kodwa-ke, kufanele kuqashelwe ukuthi ayikho into enjengale engenabungozi ngokuphelele. Ama-SARM okwamanje awavunyelwe yi-US Food and Drug Administration (FDA) ukuze asetshenziswe. 

Ucwaningo seluqale ukwenzeka emashumini ambalwa eminyaka adlule, futhi alukathuthuki ngokwanele ukuhlonza imiphumela yesikhathi eside yokusebenzisa izinto ezifana ne-Selective Androgen Receptor Modulators. 

Nakuba lolu cwaningo lwangaphambili lubonisa izinzuzo zezokwelapha, lokhu akufanele kufifuze ingozi engaba khona yezimo ezifana nokuhlaselwa yinhliziyo nokulimala kwesibindi. 

I-LGD-4033 ne-MK-2866, kokubili ama-SARM, kukhona hhayi kwabesifazane abakhulelwe nabancelisayo, noma labo okungenzeka ukuthi bakhulelwe. Zikhona futhi hhayi ukusetshenziswa izingane. Ngokufanayo, nabo sakufanele kucatshangelwe yilabo abane-hypersensitivity ezingxenyeni zabo ezisebenzayo noma ezingasebenzi. Akekho uchwepheshe wezokwelapha ohloniphekile ozobeka noma iyiphi i-SARM uma uhlangabezana nalezi zindlela. 

Kubalulekile kubasebenzisi abangaba khona be-Ostarine (MK-2866) kanye ne-Ligandrol (LGD-4033) ukuze bafune isiqondiso sezokwelapha sangaphambili, futhi bathathe izinyathelo ezengeziwe kuphela ngemvume evela kudokotela wabo. Ngaphezu kwalokho, imithamo yalawa ma-SARM akufanele neze ihlukunyezwe ngethemba lemiphumela esheshayo. Lokhu kuzohlala kubangela imiphumela engemihle - kungakhathaliseki ukuthi incane noma iyingozi kakhulu. 

Abasebenzisi kufanele bafune isiqondiso sezokwelapha ngokushesha uma behlangabezana nanoma yikuphi ukungavamile. Ngaphezu kwalokho, kufanele uthenge i-MK-2866 kuphela noma uthenge i-LGD-4033 esitolo esidumile sama-SARM. Lokhu kuzoqinisekisa ukuthi zivela kumthengisi wekhwalithi osebenza kuphela ngezithasiselo ezisemthethweni. 

Izinzuzo ezingaba khona ze-LGD-4033: LGD vs Ostarine

I-Ligandrol, eyaziwa nangokuthi I-LGD-4033, cishe ingenye ethandwa kakhulu kuwo wonke ama-SARM okwakha inqwaba. Ine-anabolic ku-androgenic ratio ye-10: 1 - lokho kwanele ukuphakamisa amandla ayo. 

Ukusetshenziswa kwe-Ligandrol kuhlotshaniswa nezithuthukisi ezimangalisayo ku-bone mineral density, ezingaphansi kocwaningo lokwelashwa kwazo kwezimo ezinzima zempilo njenge-osteoporosis. 

Ngaphezu kwalokhu, i-Ligandrol ibonisa ukusebenza kahle ekunikezeni amandla emisipha. Kuyasiza ukugcina isisindo somzimba wabasebenzisi singaguquguquki, futhi inamandla okukhiqiza imisipha ethambile ngaphandle kokuqongelela amafutha amaningi. Lawa manoni ayisitha sakho uma ungumuntu ojwayelekile ejimini! 

Ngamanye amazwi, i-LGD-4033 iqinisekisa ukuthi kukhona ukuwohloka okuncane kwemisipha phakathi kokwakhiwa komzimba okunamandla kanye nezikhathi zokuzivocavoca. Akumangalisi-ke ukuthi abanye abasebenzisi bathi kulula ukulahlekelwa amafutha emzimbeni. Akukhona lokhu kuphela, kodwa i-Ligandrol inekhono eliyingqayizivele lokwandisa ukusatshalaliswa nokuthathwa kweglucose. Kulokhu, kungathuthukisa ukusetshenziswa nokusabalalisa ama-carbohydrate, amaprotheni, nezinye izakhi. 

Ukwakhiwa kwemisipha emadodeni, i-Ligandrol ivame ukusetshenziswa kumithamo ye-10mg ngosuku, nomjikelezo othatha amasonto e-8-12. Kungcono kuthathwe kanye nokudla. Abasebenzisi besifazane, ngakolunye uhlangothi, kufanele basebenzise umthamo omncane kanye nomjikelezo omfushane: 5mg ngosuku ngokudla, emjikelezweni ohlala phakathi kwe-6 ne-10 amasonto. 

Kubalulekile ukukhumbula ukuthi ukusetshenziswa kwe-Ligandrol kuhambisana kahle nokudla okulinganiselayo kanye nezikhathi zokuzivocavoca eziqondisiwe. Akukona nje kuphela ukuthi zibalulekile empilweni jikelele, kodwa labo abafuna ukunciphisa amafutha noma ukuzuza imisipha abakwazi ukwenza lokho ngaphandle kokufaka okuthile okuvela endleleni yabo yokuphila. Lezi zithako azihloselwe ukuba zibe ukulungisa okusheshayo noma esikhundleni sokuvivinya umzimba: ziyimithi esekhona ekuqaleni kocwaningo lwazo, eklanyelwe ukusiza abasebenzisi bayo ukuba baye esakhiweni somzimba esinempilo kubo. 

Lesi esinye isizathu sokuthi kungani kufanele ufune iseluleko sezokwelapha futhi ulinde ukuthi unikezwe ama-SARM: umzimba womuntu wonke uhlukile, futhi ukwakheka komzimba okufanele basebenzele kukho kumuntu ngamunye ngokuphelele. 

Uma ucabangela umbuzo othi "Ligandrol vs Ostarine", i-Ligandrol ihloselwe ukwandisa isisindo somzimba ngakho-ke akukhuthazwa uma ubheka ukunciphisa isisindo somzimba wakho wonke. 

Lesi sengezo singenziwa ingxenye yakho kokubili imijikelezo yokubhuqa kanye nokusika, lapho inhloso kuwukulahlekelwa amafutha omzimba ngenkathi usakha imisipha ethambile. Uma ucabangela i-Ligandrol vs Ostarine, i-Ligandrol icindezela kancane, inamandla kakhulu, futhi i-anabolic kakhulu kune-MK-2866, ngakho-ke ngezinye izikhathi ibizwa ngokuthi "umfowabo omkhulu we-MK-2866". I-LGD-4033 ifaneleka kakhulu ukukhahlela, ukusetshenziswa komjikelezo, futhi njengengxenye yebhuloho. 

Uma ungumdlali ohlolwe ngaphansi kwe-World Anti-Doping Agency, kubalulekile ukuthi uqaphele ukuthi i-LGD-4033 ibhekwa njengesidakamizwa esithuthukisa ukusebenza (PED) ngakho-ke ivinjelwe. Ngakho-ke, akufanele usebenzise lesi sidakamizwa uma wenza ngokuncintisana noma uma uzohlolwa phakathi kwamaviki angu-4-6 alandelayo. 

Izinzuzo ezingaba khona ze-MK-2866: I-Ostarine vs Ligandrol

I-MK-2866, eyaziwa nangokuthi i-Ostarine, i-Ostabolic, noma i-Enobosarm, i-Selective Androgen Receptor Modulator enekhono lokubopha ngokuqondile nama-androgen receptors ukwandisa amaprotheni synthesis emathanjeni nasemisipha. 

Kuphawulwa njengenye ye-SARM ephumelela kakhulu uma kuziwa ekulondolozeni imisipha ekulahlekeni kwekhalori nokubambelela emandleni ngenkathi uthola i-shredded. 

Abantu abaningi bayakwazisa ukukwazi ukugcina izinzuzo zabo ngenkathi besakwazi ukulahlekelwa isisindo somzimba, bengeza lokhu njengento engaba khona engxoxweni ethi "Ostarine vs Ligandrol". Ngokuvamile, abasubathi bachitha isikhathi nomzamo bethola isisindo, kodwa baqaphele ukukhuphuka kwezikali. Khona-ke, bazozama ukunciphisa umzimba - futhi imisipha iyanyamalala! Abasebenzisi akufanele baqaphele umehluko kuzinga labo lamandla uma behlisa isisindo, inqobo nje uma kwenzeka kancane kancane futhi ngaphakathi kwebanga elinempilo kumuntu ngamunye. 

Lokhu kufanele futhi kubhekwe ngokuphambene uma kuziwa ekwelapheni izimo ezifana nezinkinga zokumosha imisipha. Kubalulekile ukuthi ungavumeli isisindo somzimba sehle kakhulu, ikakhulukazi uma isisindo somzimba sesivele siphansi. Ukusebenzisa izithasiselo ezandisa ukwehla kwesisindo kungaba yingozi emangalisayo uma umuntu esevele ene-BMI ephansi. Futhi, lokhu kuyinto okufanele wena nodokotela wakho nixoxe ngayo ngaphambi kokuba banikeze noma yiluphi uhlobo lokwelashwa. 

Enye yezinzuzo ezinkulu ze-Ostarine ukuthi imnene kakhulu uma iqhathaniswa namanye ama-Selective Androgen Receptor Modulators. Leli elinye lamaphuzu amakhulu okufanele icatshangelwe lapho ukala umbuzo we-LGD vs Ostarine. Uma umusha kuma-SARM, kuhlale kungcono kakhulu ukuqala kancane futhi ngokucophelela. 

Akukhona lokhu kuphela, inamandla ayingqayizivele okugcina nokwakha imisipha yemisipha. Uma kungagcini lapho, kuyasiza ukupakisha ukuqina namandla amaningi kanye nenani elifanele lesisindo somzimba nosayizi. Umphumela ohlaba umxhwele kakhulu ukuthi usayizi ozuziwe uzoba owomile, izicubu zomzimba ezithambile. 

I-MK-2866 yenza kube lula kakhulu kubasebenzisi ukuthi baqaphele noma yikuphi phakathi kuka-5 no-10lbs wekhwalithi yenzuzo yemisipha, phakathi nesikhathi esifushane njengamaviki angu-4-6. Lezi zinzuzo "ziyagcinwa" phezu kwalokho!

Ngaphezu kwalokho, i-MK-2866 iphinde ibonise ukusebenza kahle ekunciphiseni ingozi yezifo eziwohlokayo kanye nezinkinga. Lokhu ikakhulukazi uma abasebenzisi belulama ekuhlinzweni noma kwezinye izimo zezempilo ezifanayo. Ngaphezu kwalokho, imiphumela ye-anabolic ye-MK-2866 mihle ngokulinganayo ukuthi ingaqondi nje izicubu zemisipha kodwa futhi ifinyelele izicubu zemisipha yamathambo nethambo. 

Uma kuziwa ku-MK-2866 vs LGD-4033, i-MK-2866 nayo iyasiza ekuthuthukiseni umzimba nokuthuthukisa ukusebenza kwezemidlalo. Le SARM kubikwa ukuthi inikeza izinzuzo ezifanayo kuma-anabolic steroids, kodwa ngokunciphisa ingozi yeminye yemiphumela yabo emibi. 

Ezinye zalezi zingabandakanya ukwanda kwendlala yesinye, ukuqothuka kwezinwele, izinduna, ukushintshashintsha kwemizwelo, i-hypertrophy yenhliziyo, ubuthi besibindi, umfutho wegazi ophakeme, nokumiswa kwe-testosterone yemvelo. 

Lezi zingozi ziphansi kakhulu kune-anabolic steroids, kodwa azisoze zenzeke; ngakho-ke sicela ukhumbule ukusebenzisa ukuqapha okuphelele futhi wenze ucwaningo lwakho ngaphambi kokucabangela noma yiluphi uhlobo lwesithasiselo. 

 

I-Ligandrol vs Ostarine: Yini Ngokulandelayo?

Isilinganiso esifanele se-Ostarine yi-25-50mg nsuku zonke kumadoda, emjikelezweni wamaviki e-8-12. Okufanelekile, kufanele kuthathwe njalo nokudla. Abasebenzisi besifazane bangasebenzisa le SARM emjikelezweni wamaviki e-6-8 ngesilinganiso sansuku zonke se-12.5mg nsuku zonke.

Ifaneleka kakhulu ukuhlanganisa kabusha, ukunqwabelana, noma ukusika. Kodwa-ke, isetshenziswa kakhulu njengesidakamizwa somjikelezo wokusika esiza abasebenzisi ukuthi balondoloze isisindo somzimba namandla ngesikhathi sokwakha umzimba, i-cardio, kanye nezikhathi zokuzivocavoca. 

Kuphakanyiswa ukuthi abasebenzisi balandele ukwelashwa okuphelele kwangemuva komjikelezo (PCT) ngemva komjikelezo ngamunye we-MK-2866. Funda kabanzi mayelana nokwelashwa kwangemuva komjikelezo kanye nokubaluleka kwakho kokuthunyelwe kwebhulogi lapha. 

Kubalulekile futhi ukuqaphela ukuthi i-MK-2866 ithathwa njengesidakamizwa esithuthukisa ukusebenza (PED) futhi ngenxa yalokho ivinjelwe. Uma ungumdlali ohlolwe ngaphansi kwe-World Anti-Doping Agency, akufanele usebenzise lesi sidakamizwa uma uzoqhudelana noma uhlolwe phakathi kwamaviki angu-4-6. 

 

I-LGD vs Ostarine: Uyini Umehluko?

• I-Ostarine iyi-SARM eyakhiwe ukuze iphathe kokubili izimo zokuchithwa kwemisipha kanye ne-osteoporosis. Ngakolunye uhlangothi, i-LGD-4033 yathuthukiswa ukuphatha isisindo semisipha ngenxa yezinkinga zempilo ezahlukene.
• I-LGD-4033 ine-half-life yamahora angu-24-26, kuyilapho i-Ostarine ine-half-life yamahora angu-20-24. Lokhu akusho ngempela ukuthi kufanele ziphuzwe kaningi noma kancane kunezinye: kanye ngosuku ngokudla isincomo esimaphakathi sakho kokubili. Kuyafaneleka ukucabangela ukuthi imiphumela ye-Ligandrol izohlala isikhathi eside kakhulu; kodwa-ke, uma udla, ulala, futhi uzivocavoca phakathi nezikhathi ezifanele, ungase ungawuboni lo mehluko wamahora angu-0-6. 
• I-Ostarine vs LGD: Ukusetshenziswa kwe-Ostarine kungaholela ekukhuphukeni okuncane emazingeni e-estrogen, kuyilapho ukusetshenziswa kwe-Ligandrol kungabangela ukunciphisa kancane emazingeni e-globulin ebopha i-hormone yocansi kanye ne-testosterone.
• I-Ostarine vs LGD: I-Ostarine icindezela kancane futhi i-LGD-4033 icindezela kakhulu ngokuqhathaniswa. 
• I-LGD-4033 ifaneleka kakhulu kubasebenzisi asebevele bangene emijikelezweni embalwa yama-SARM. I-Ostarine, ngakolunye uhlangothi, ilungele kakhulu abaqalayo kanye nabasebenzisi abanolwazi.
• I-MK-2866 vs LGD-4033: I-LGD-4033 ifaneleka kakhulu emijikelezweni yobuningi, futhi i-MK-2866 ilungele ukusika imijikelezo.

I-Ostarine vs LGD: Isinqumo?

Kokubili i-Ostarine (MK-2866) inezinzuzo zayo kanye nezithiyo, futhi ukukhethwa kokugcina phakathi kokubili kuncike ngokuphelele ezidingweni ezithile zabasebenzisi. Uma ubheka ukwandisa imisipha, i-LGD-4033 ifaneleka kangcono, futhi i-MK-2866 iyisinqumo esithandwayo se-SARM yomjikelezo wokusika. Umbuzo othi "Ligandrol vs Ostarine" uphansi kuwe, ucwaningo lwakho, imigomo yakho, kanye nesiqondiso sikadokotela wakho yedwa.